Index of reports
> Cases with Abdominal Pain (20)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Hydrocortisone (Hydrocortisone Topical) where reactions include abdominal pain. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Hydrocortisone side effects in
Reported by a physician from United States on 2012-08-22
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Methotrexate Sodium
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Doxorubicin HCL
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin
Possible Hydrocortisone side effects in
Reported by a physician from United States on 2012-08-20
Patient:
Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin
Possible Hydrocortisone side effects in
Reported by a physician from United States on 2012-08-14
Patient:
Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
Indication: Acute Lymphocytic Leukaemia
Bortezomib
Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
Indication: Acute Lymphocytic Leukaemia
Doxorubicin Hydrochloride
Dosage: given over 15-30 minutes on day 1
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 2500 units/m2/dose as 4 weekly doses
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: on days 8, 15 and 22
Indication: Acute Lymphocytic Leukaemia
Dexamethasone
Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole
Possible Hydrocortisone side effects in
Reported by a physician from United Kingdom on 2012-07-17
Patient:
Reactions: Abdominal Pain, Tachycardia, Skin Toxicity, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Dizziness, Oedema, Hallucination, Vomiting, Nausea, Gastrointestinal Toxicity, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Condition Aggravated, Adult T-Cell Lymphoma / Leukaemia, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Acyclovir; Thiabendazole; Cotrim; Itraconazole
Possible Hydrocortisone side effects in
Reported by a physician from United Kingdom on 2012-07-10
Patient:
Reactions: Abdominal Pain, Skin Toxicity, Tachycardia, Pyrexia, Fatigue, Neuropathy Peripheral, Hepatotoxicity, Adverse Event, Oedema, Dizziness, Hallucination, Vomiting, Gastrointestinal Toxicity, Nausea, Neutropenic Sepsis, Nephropathy Toxic, Hypotension, Adult T-Cell Lymphoma / Leukaemia, Condition Aggravated, Mucosal Inflammation, Lung Disorder, Infection, Infusion Related Reaction
Adverse event resulted in: death
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Prednisolone
Dosage: on days 1-5 of 21 day cycle, (cycle 1-5)
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Cytarabine
Indication: Adult T-Cell Lymphoma / Leukaemia
Doxorubicin HCL
Dosage: on day 1 of 21 day, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Vincristine
Dosage: (maximum 2 mg) on day 1 of 21 day cycle, (cycle 1-5)
Indication: Adult T-Cell Lymphoma / Leukaemia
Methotrexate
Indication: Adult T-Cell Lymphoma / Leukaemia
Zenapax
Dosage: on days 7 and 14 on cycle 1 of 21 day cycle
Indication: Adult T-Cell Lymphoma / Leukaemia
Hydrocortisone
Indication: Adult T-Cell Lymphoma / Leukaemia
Radiotherapy
Indication: Adult T-Cell Lymphoma / Leukaemia
Other drugs received by patient: Cotrim; Itraconazole; Thiabendazole; Acyclovir
Possible Hydrocortisone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from Spain on 2012-07-05
Patient: 10 year old female
Reactions: Cushingoid, Abdominal Pain, Coagulopathy, Hyponatraemia, Hyperviscosity Syndrome, Headache, Pallor, Somnolence, Hepatic Enzyme Increased, Malaise, Nervous System Disorder, Oedema, Asthenia, Hypertriglyceridaemia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Dosage: 8 mg/m2, per day
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Hydrocortisone
Dosage: 30 mg, unk
Indication: Acute Lymphocytic Leukaemia
Asparaginase
Dosage: 10000 iu/m2, per day
Indication: Acute Lymphocytic Leukaemia
Prednisone
Indication: Acute Lymphocytic Leukaemia
Other drugs received by patient: Epirubicin; Methotrexate; Cytarabine; Daunorubicin HCL; Methotrexate W / Cytarabine / Hydrocortisone; Vincristine; Cyclophosphamide; Mercaptopurine
Possible Hydrocortisone side effects in 13 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23
Patient: 13 year old male
Reactions: Klebsiella Infection, Abdominal Pain, Diarrhoea, Fungal Infection, Blood Culture Positive, Bacterial Infection, Aplasia, Candidiasis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-09
End date: 2011-10-03
Hydrocortisone
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Cerubidine
Dosage: intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Vincristine Sulfate
Dosage: in accordance with the cycle,intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-16
End date: 2011-09-30
Cytarabine
Dosage: intradiscal (intraspinal)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
(Kidrolase)
Dosage: intravenous (not otherwise specified)
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-09-20
End date: 2011-10-03
Other drugs received by patient: Bactrim; (Amiklin / 00391001 / ); Tazobactam; Solupred / 00016217 / ); Fasturtec
Possible Hydrocortisone side effects in 18 year old male
Reported by a physician from United States on 2012-05-10
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Pegaspargase
Dosage: 2500 iu, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-25
End date: 2012-03-02
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Vincristine
Dosage: 2 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Prednisone TAB
Dosage: 50 mg, bid
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Cytarabine
Dosage: 70 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Possible Hydrocortisone side effects in male
Reported by a physician from United States on 2012-04-30
Patient: male
Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Mucosal Inflammation, Dysgeusia, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite
Drug(s) suspected as cause:
Hydrocortisone
Indication: Prostate Cancer Metastatic
Ketoconazole
Administration route: Oral
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist
Possible Hydrocortisone side effects in 18 year old male
Reported by a consumer/non-health professional from United States on 2012-04-13
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Prednisone TAB
Dosage: 50 mg, bid
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Pegaspargase
Dosage: 2500 iu, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-25
End date: 2012-03-02
Cytarabine
Dosage: 70 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Possible Hydrocortisone side effects in 10 year old female
Reported by a physician from United States on 2012-04-05
Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)
Reactions: Abdominal Pain, Headache, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Rash Pustular, Back Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Hypophosphataemia, Respiratory Tract Infection, Neuralgia, Enterocolitis Infectious
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-27
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-14
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Pegaspargase
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-15
End date: 2011-12-29
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-29
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-17
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Possible Hydrocortisone side effects in 18 year old male
Reported by a physician from United States on 2012-04-03
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: White Blood Cell Count Decreased, Abdominal Pain, Metabolic Acidosis, Clostridium Test Positive, Urine Output Decreased, Hypotension, Hyponatraemia, Capillary Leak Syndrome, Platelet Count Decreased, Septic Shock
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Oncaspar
Dosage: 2500 iu;x1;iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Doxorubicin HCL
Dosage: 60 mg/m**2;x1;iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Velcade
Dosage: 1.3 mg/m**2; qd; iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Vincristine
Dosage: 1.5 mg/m**2;qd;iv
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Prednisone TAB
Dosage: 20 mg/m**2;qd;po
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Cytarabine
Dosage: 70 mg;x1;inth
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-24
Hydrocortisone
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: inth
Indication: Acute Lymphocytic Leukaemia
Possible Hydrocortisone side effects in 10 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-29
Patient: 10 year old female, weighing 20.9 kg (46.0 pounds)
Reactions: Abdominal Pain, Pain in Extremity, Pain, Hypoxia, Cerebrovascular Accident
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fentanyl
Indication: Pain
Mercaptopurine
Indication: Product Used FOR Unknown Indication
Hydrocortisone
Dosage: unk mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-17
End date: 2012-02-17
Methadone HCL
Indication: Pain
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-17
End date: 2012-02-24
Cyclophosphamide
Dosage: 440 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-17
End date: 2012-02-21
Etoposide
Dosage: 100 mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-17
End date: 2012-02-21
Methotrexate
Dosage: unk mg/m2, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-17
End date: 2012-02-17
Cytarabine
Dosage: unk mg, cyclic
Indication: Acute Lymphocytic Leukaemia
Start date: 2012-02-17
End date: 2012-02-17
Possible Hydrocortisone side effects in 18 year old male
Reported by a consumer/non-health professional from United States on 2012-03-13
Patient: 18 year old male, weighing 126.4 kg (278.1 pounds)
Reactions: Abdominal Pain, White Blood Cell Count Decreased, Hypotension, Hyponatraemia, Acidosis, Capillary Leak Syndrome, Sepsis, Platelet Count Decreased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-02-24
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Cytarabine
Dosage: 70 mg, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
Pegaspargase
Dosage: 2500 iu, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-02
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Prednisone TAB
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2012-02-24
End date: 2012-03-04
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Possible Hydrocortisone side effects in 10 year old female
Reported by a consumer/non-health professional from United States on 2012-03-09
Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)
Reactions: Abdominal Pain, Confusional State, Lung Infection, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Fungaemia, Hypoxia, Clostridial Infection, Back Pain, Rash Pustular, Vomiting, Nausea, Pain in Extremity, Lung Neoplasm, Hypotension, Febrile Neutropenia, Pancytopenia, Hyponatraemia, Hypophosphataemia, Diarrhoea, NO Therapeutic Response, Sepsis, Hypophagia, Respiratory Tract Infection, Enterocolitis Infectious, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegaspargase
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-15
End date: 2011-12-29
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-14
Prednisone
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-27
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-29
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-17
Possible Hydrocortisone side effects in male
Reported by a physician from United States on 2012-03-07
Patient: male
Reactions: Abdominal Pain, Vomiting, Nausea, Flatulence, Rash, Dysgeusia, Mucosal Inflammation, Fatigue, Hepatotoxicity, Diarrhoea, Dizziness, Decreased Appetite
Drug(s) suspected as cause:
Hydrocortisone
Indication: Prostate Cancer Metastatic
Ketoconazole
Administration route: Oral
Indication: Prostate Cancer Metastatic
Other drugs received by patient: Gonadotropin-Releasing Hormone Agonist
Possible Hydrocortisone side effects in 10 year old female
Reported by a physician from United States on 2012-01-24
Patient: 10 year old female, weighing 20.8 kg (45.8 pounds)
Reactions: Back Pain, Rash Pustular, Abdominal Pain, Nausea, Pain in Extremity, Hypotension, Hyponatraemia, Febrile Neutropenia, Headache, Peripheral Sensory Neuropathy, Caecitis, Hypokalaemia, Hypophosphataemia, Fungaemia, Hypoxia, Respiratory Tract Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-17
Prednisone TAB
Dosage: 20 mg/m2, cyclic
Administration route: Oral
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-27
Vincristine
Dosage: 1.5 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-29
Pegaspargase
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-15
End date: 2011-12-29
Methotrexate
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Doxorubicin HCL
Dosage: 60 mg/m2, cyclic
Indication: B Precursor Type Acute Leukaemia
Start date: 2011-12-14
End date: 2011-12-14
Cytarabine
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Hydrocortisone
Dosage: unk
Indication: B Precursor Type Acute Leukaemia
End date: 2011-12-29
Possible Hydrocortisone side effects in 72 year old female
Reported by a consumer/non-health professional from United States on 2011-11-09
Patient: 72 year old female, weighing 81.6 kg (179.6 pounds)
Reactions: Irritability, Burning Sensation, Abdominal Pain, Nausea, Pain
Drug(s) suspected as cause:
Hydrocortisone
Possible Hydrocortisone side effects in female
Reported by a physician from Canada on 2011-11-02
Patient: female, weighing 97.6 kg (214.7 pounds)
Reactions: Abdominal Pain, Fistula, Drug Ineffective, Crohn's Disease, Pain, Gastrointestinal Inflammation, Drug Dependence, Abscess Intestinal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Start date: 2011-06-07
End date: 2011-09-06
Hydrocortisone
Administration route: Oral
Indication: Abscess Intestinal
Start date: 2011-05-06
Hydrocortisone
Indication: Inflammation
Humira
Indication: Crohn's Disease
Start date: 2009-08-11
End date: 2011-06-07
Humira
Start date: 2011-05-16
End date: 2011-06-01
Other drugs received by patient: Calcium with Vitamin D; Elavil
Possible Hydrocortisone side effects in 11 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-28
Patient: 11 year old female, weighing 35.0 kg (77.0 pounds)
Reactions: Abdominal Pain, Hepatic Function Abnormal, Hypersensitivity, Pain, Rectal Haemorrhage, Extrasystoles, Coagulopathy, Headache, Skin Hyperpigmentation, Caecitis, Erythema, Multi-Organ Failure, Dyspepsia, Chest Pain, Renal Failure Acute, Heart Rate Abnormal, Anuria, Pain in Extremity, Hypotension, Musculoskeletal Pain, Atrial Fibrillation, Rash, Arrhythmia, Acute Lymphocytic Leukaemia, Mucosal Inflammation, Oral Pain, Respiratory Failure, Rash Erythematous, Heart Rate Increased, Electrocardiogram P Wave Abnormal
Adverse event resulted in: death
Drug(s) suspected as cause:
Evoltra
Dosage: 48 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-06-17
End date: 2011-06-21
Dexamethasone
Dosage: 6 mg, bid
Administration route: Oral
Start date: 2011-05-26
End date: 2011-06-08
Dexamethasone
Dosage: 6 mg, bid
Administration route: Oral
Start date: 2011-06-17
End date: 2011-06-23
Cytarabine
Dosage: 30 mg, 1x/w
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-11
End date: 2011-06-08
Methotrexate
Dosage: 12 mg, 1x/w
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-11
End date: 2011-06-22
Etoposide
Dosage: 120 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-12
End date: 2011-05-16
PEG-Asparaginase
Dosage: 1200 iu, q2w
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-12
End date: 2011-05-26
Hydrocortisone
Dosage: 12.5 mg, 1x/w
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-11
End date: 2011-06-08
Vincristine
Dosage: 1.7 mg, 1x/w
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-12
End date: 2011-06-02
Cyclophosphamide
Dosage: 360 mg, qd
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-06-17
End date: 2011-06-21
Dexamethasone
Dosage: 6 mg, bid
Administration route: Oral
Indication: Acute Lymphocytic Leukaemia
Start date: 2011-05-12
End date: 2011-05-18
Etoposide
Dosage: 120 mg, qd
Start date: 2011-06-17
End date: 2011-06-21
Dexamethasone
Dosage: 6 mg, bid
Administration route: Oral
Start date: 2011-07-01
End date: 2011-07-07
Other drugs received by patient: Allopurinol; Cotrim; Levomepromazine; Piperacillin W; Acetaminophen; Ambisome; Acetaminophen; Allopurinol; Ondansetron; Ciprofloxacin; Levomepromazine; Omeprazole; Ondansetron; Penicillin V; Cotrim; Metronidazole
|